Longboard Pharmaceuticals announces $150M common stock offering

Longboard Pharmaceuticals announced that it has commenced an underwritten public offering, subject to market and other conditions, to issue and sell $150M of shares of its voting common stock. Cantor and Citigroup are acting as joint lead book-running managers for the proposed offering, and Wedbush PacGrow and H.C. Wainwright & Co. are acting as lead managers for the proposed offering.